RxDoctor Payments Data

Chelsea Norcross

Surgical · Rochester, NYNPI 1023128709

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,303 of the $3,250 with a category attached, or 70.9%. 17 manufacturers reported payments, led by Medtronic at 37.1% of the total. Reporting peaked in 2023 at $1,518 and has fallen 72.9% since, to $411 in 2025. Among surgical clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,250in general payments, 2019–2025

Across 57 payments — averaging $57.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Baxter Healthcare$860
  • Mimedx Group, Inc.$171
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$147
  • Boston Scientific$141
  • Johnson & Johnson$130
  • plus $594 from 11 others

What the payments were for

  • Travel & lodging$94729%
  • Food & beverage$2,30371%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,250 in reported general payments places this provider in the 90th percentile of 1,544 surgical providers in New York.

See all surgical providers in New York →

Medicare billing

Part B allowed, 2024
$2,333
Medicare patients
11
Services billed
18

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine24$278
ClopidogrelClopidogrel Bisulfate39$264
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$176
Atorvastatin Calcium18$158
Metoprolol Succinate11$124
Warfarin Sodium16$116
Metoprolol Tartrate23$71

Paid to pharmacies, not to this prescriber.

Other surgical in Rochester

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →